kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human PD-L2 / B7-DC Protein, (HPLC-verified), Fc Tag, 100µg  

Recombinant Human PD-L2 / B7-DC Protein, (HPLC-verified), Fc Tag, 100µg

Recombinant human PD-L2 / B7-DC Protein, Leu 20 - Pro 219, produced in human 293 cells (HEK293), HPLC-verified, Fc Tag

recombinant human protein PDL2, PD-L2, Butyrophilin B7-DC, CD273, PDCD1 ligand 2, PDCD1L2, PDCD1LG2

More details


Availability: within 7 days

312,00 €

Programmed cell death 1 ligand 2 (PD-L2 or PDCD1 ligand 2) is also known as Butyrophilin B7-DC, CD antigen CD273, which belongs to the immunoglobulin superfamily or BTN/MOG family. The expression of PD-L2 is up-regulated by IFNG/IFN-gamma stimulation in monocytes and induced on dendritic cells grown from peripheral blood mononuclear cells with CSF2 and IL-4. PD-L2 Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. PD-L2 interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.

Recombinant Human PD-L2, Fc Tag (HPLC verified) (PD2-H5251) is expressed from human 293 cells (HEK293). It contains AA Leu 20 - Pro 219 (Accession # AAI13679).
Predicted N-terminus: Leu 20

Molecular Characterization
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 49.2 kDa. The protein migrates as 60-70 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Less than 1.0 EU per μg of the Human PD-L2, Fc Tag (HPLC-verified) by the LAL method.

>95% as determined by SDS-PAGE.
>90% as determined by SEC-HPLC.

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

See Certificate of Analysis for details of reconstitution instruction and specific concentration.

For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Please refer to product data sheet.

Clinical and Translational Updates

(1) "Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis"
Panezai, Ghaffar, Altamash et al
Biomedicines (2022) 10 (3)
(2) "Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity"
Hellbacher, Sundström, Molin et al
Cancers (Basel) (2022) 14 (6)
(3) "Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database"
Wu, Liu, Hu et al
Hereditas (2022) 159 (1), 18
Showing 1-3 of 1267 papers.


(1) "Novel anti-PD-1 antibodies"
Authors: X Qian, et al
Journal: US20190330348A1 2019
Application: ELISA
(2) "PD-L1 Specific Monoclonal Antibodies for Disease Treatment and Diagnosis"
Authors: Wang Aijun, et al.
Journal: US20170355770A1 2017
Application: ELISA

The following products could also be interesting for you: